ROLE OF DASHMULADI COMPOUND IN THE MANAGEMENT OF BENIGN PROSTATIC HYPERTROPHY (ASTHEELA)

Abstract

Benign Prostatic Hypertrophy (Ashtheela or Vatastheela) is a type of disease which is mentioned under Mutraghata disorders in the Sushruta Samhita. Astheela as described in Ayurveda, occurs normally at the age of 40 or above and also associated with sexual dysfunction. Management of Ashtheela with Ayurvedic approach, using herbal medicines, is far better approach. Dashmuladi compound is prescribed in Yog Ratnakar for treatment of Ashtheela (BPH), however the reports pertaining the therapeutic uses of Dashmuladi in the management of Astheela are scarce. Therefore, this study has been undertaken to assess the clinical efficacy and safety of Dashmuladi compound in the management of BPH (Astheela). The patients were randomly and divided into two groups. In first group, placebo capsule was given orally twice a day with lukewarm water for 45 days; in second group, one capsule (500 mg) of Shilajit was given twice a day with lukewarm of Dashmul kwath for 45 days. Results showed that control group showed significantly greater relief in the subjective parameters then placebo group. However, reduction in the size of the prostate and in the volume of the post-void residual urine was found much better in the control group.